Report Detail

Request for Sample of this report

Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country

RnM3926486
13 March, 2020
Global
229 Pages
The Insight Partners
Other

European colorectal cancer market, is anticipated to reach US$ 5,573.2 Mn in 2027 from US$ 4,241.2 Mn in 2019. The market is projected to grow with a CAGR of 3.5% from 2020-2027.
The colorectal cancer market is growing primarily due to the increasing prevalence of colorectal cancer, and benefits offered by generic drugs that are boosting the market over the years. Restraining factors, such as pricing pressure on drug manufacturers, are likely to damage the growth of the market in the coming years. On the other hand, rising healthcare expenditure in Europe is expected to have a positive impact on the growth of the Europe colorectal cancer market in the coming years.
Colorectal cancer is also known as colon cancer, bowel cancer, or rectal cancer. This type of cancer is the second leading cause of death in women and third in men. Colorectal cancer may be benign, or non-cancerous, or malignant. The symptoms shown by the patients who have colon cancer include changes in bowel habits, diarrhea or constipation, blood in stools that make it look black. Colorectal cancer can be treated with chemotherapy, radiotherapy, and surgery.
Colorectal cancer is one of the commonly found and lethal cancers which is developed in an individual with the combined influence of genetic and environmental factors. Additionally, according to the World Health Organization (WHO), colorectal cancer was the third most prevalent form of cancers, with approximately 1.80 million cases around the world in 2018, excluding skin cancer. The rates of colorectal cancer mortality and incidence vary across the globe as per the reports by WHO’s cancer database GLOBOCAN. The GLOBOCAN reports approximately 861,000 deaths in 2018 due to colorectal cancer. The colorectal cancer is found among the significant population in the North American regions. For instance, according to the Centers for Disease Control and Prevention (CDC) and American Cancer Society, an estimated 145,600 adults in the United States were diagnosed, and 51,020 deaths were reported with colorectal cancer in 2018. The trend of the high presence of cancer is also similar in European countries. For instance, according to Cancer Research UK, deaths from bowel/colorectal cancer in the UK between 2015 and 2017 were reported to be 16,272. Moreover, the data also suggests approximately 42,000 new bowel cancer cases in the UK every year, which are more than 110 patients each day. Thus, the rising number of patients suffering with the disease is likely to drive the growth of colorectal cancer during the forecast period..
In 2019, the diagnosis type accounted for the largest market share in the Europe colorectal cancer market. The growth of diagnosis type is expected to grow due to rising colorectal screening programs and initiatives across the world. The diagnosis type segment is also estimated to mark the highest CAGR in the market during the forecast period, owing to the increasing technological development that is enabling the early detection of colorectal cancer by the various method of screenings.
In 2019, the hospitals segment held the most significant market share of the colorectal cancer market by the end user. This segment is also anticipated to hold a considerable portion of the market in 2027, owing to the need for hospitals as primary healthcare centers for the people. The segment is also anticipated to witness growth at a significant rate during the forecast period.
Some of the significant primary and secondary sources for colorectal cancer included in the report are Asociación Española Contra El Cáncer (AECC), Italian Association For Cancer Research (AIRC), Centre For The Development Of Industrial Technology (CDTI), European Commission Initiative On Colorectal Cancer (ECICC) and others.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Colorectal Cancer Market – By Modality
- 1.3.2 Europe Colorectal Cancer Market – By End User
- 1.3.3 Europe Colorectal Cancer Market – By Country

2. Europe Colorectal Cancer Market – Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Colorectal Cancer Market – Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Colorectal Cancer Market - Europe PEST Analysis

5. Europe Colorectal Cancer Market - Key Market Dynamics

5.1 Key Market Drivers
- 5.1.1 Increasing Prevalence Of Colorectal Cancer
- 5.1.2 Benefits Offered By Generic Drugs
5.2 Key Restraints
- 5.2.1 Pricing Pressure On Drug Manufacturers
5.3 Key Market Opportunities
- 5.3.1 Rising Healthcare Expenditure in Europe
5.4 Future Trend
- 5.4.1 Inclination Towards Personalized Medicine
5.5 Impact Analysis

6. Colorectal Cancer Market – Europe Analysis

6.1 Europe Colorectal Cancer Market Revenue Forecasts and Analysis
6.2 Positioning Of Key Players

7. Europe Colorectal Cancer Market Analysis And Forecasts To 2027 – Modality

7.1 Overview
7.2 Europe Colorectal Cancer Market, By Modality 2019 & 2027 (%)
- 7.2.1 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
  - 7.2.1.1 Europe Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
  - 7.2.1.2 Europe Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
  - 7.2.1.2.1 Europe Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
  - 7.2.1.2.2 Europe Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
  - 7.2.1.3 Europe Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.3 Diagnosis Type Market
- 7.3.1 Overview
- 7.3.2 Diagnosis Type Market Revenue and Forecast to 2027 (US$ Mn)
- 7.3.3 Immunohistochemistry Market
  - 7.3.3.1 Overview
  - 7.3.3.2 Immunohistochemistry Market Revenue and Forecast to 2027 (US$ Mn)
- 7.3.4 Stool Test Market
  - 7.3.4.1 Overview
  - 7.3.4.2 Stool Test Market Revenue and Forecast to 2027 (US$ Mn)
- 7.3.5 Flexible Sigmoidoscopy Market
  - 7.3.5.1 Overview
  - 7.3.5.2 Flexible Sigmoidoscopy Market Revenue and Forecast to 2027 (US$ Mn)
- 7.3.6 Colonoscopy Market
  - 7.3.6.1 Overview
  - 7.3.6.2 Colonoscopy Market Revenue and Forecast to 2027 (US$ Mn)
- 7.3.7 CEA Test Market
  - 7.3.7.1 Overview
  - 7.3.7.2 CEA Test Market Revenue and Forecast to 2027 (US$ Mn)
- 7.3.8 Other Test Market
  - 7.3.8.1 Overview
  - 7.3.8.2 Other Test Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Therapy Type Market
- 7.4.1 Overview
- 7.4.2 Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.4.3 Chemotherapy Market
  - 7.4.3.1 Overview
  - 7.4.3.2 Chemotherapy Market Revenue and Forecast to 2027 (US$ Mn)
  - 7.4.3.3 Alkylating Agent Market
  - 7.4.3.3.1 Overview
  - 7.4.3.3.2 Alkylating Agent Market Revenue and Forecast to 2027 (US$ Mn)
  - 7.4.3.4 Antimetabolites Market
  - 7.4.3.4.1 Antimetabolites Market Revenue and Forecast to 2027 (US$ Mn)
  - 7.4.3.5 Others Market
  - 7.4.3.5.1 Others Market Revenue and Forecast to 2027 (US$ Mn)
  - 7.4.4 Immunotherapy Market
    - 7.4.4.1 Overview
    - 7.4.4.2 Immunotherapy Market Revenue and Forecast to 2027 (US$ Mn)
    - 7.4.4.3 Panitumumab Market
    - 7.4.4.3.1 Overview
    - 7.4.4.3.2 Panitumumab Market Revenue and Forecast to 2027 (US$ Mn)
    - 7.4.4.4 Cetuximab Market
    - 7.4.4.4.1 Overview
    - 7.4.4.4.2 Cetuximab Market Revenue and Forecast to 2027 (US$ Mn)
    - 7.4.4.5 Bevacizumab Market
    - 7.4.4.5.1 Overview
    - 7.4.4.5.2 Bevacizumab Market Revenue and Forecast to 2027 (US$ Mn)
    - 7.4.4.6 Others Market
    - 7.4.4.6.1 Overview
    - 7.4.4.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
    - 7.4.5 Chemoprotectant Market
      - 7.4.5.1 Overview
      - 7.4.5.2 Chemoprotectant Market Revenue and Forecast to 2027 (US$ Mn)
    - 7.4.6 Others Market
      - 7.4.6.1 Overview
      - 7.4.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
  - 7.5 Imaging Type Market
    - 7.5.1 Overview
    - 7.5.2 Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)
    - 7.5.3 Computed Tomography (CT) Market
      - 7.5.3.1 Overview
      - 7.5.3.2 Computed Tomography (CT) Market Revenue and Forecast to 2027 (US$ Mn)
    - 7.5.4 Magnetic Resonance Imaging (MRI) Market
      - 7.5.4.1 Overview
      - 7.5.4.2 Magnetic Resonance Imaging (MRI) Market Revenue and Forecast to 2027 (US$ Mn)
    - 7.5.5 Others Market
      - 7.5.5.1 Overview
      - 7.5.5.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
    8. Europe Colorectal Cancer Market Analysis– By End User
    - 8.1 Overview
    - 8.2 Europe Colorectal Cancer Market, By End User 2019 & 2027 (%)
      - 8.2.1 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    - 8.3 Hospitals Market
      - 8.3.1 Overview
      - 8.3.2 Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
    - 8.4 Diagnostic and Research Laboratories Market
      - 8.4.1 Overview
      - 8.4.2 Europe Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
    9. Colorectal Cancer Market Revenue And Forecasts To 2027 – Geographical Analysis
    - 9.1 Europe Colorectal Cancer Market Revenue and Forecasts To 2027
      - 9.1.1 Overview
      - 9.1.2 Europe Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      - 9.1.3 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        9.1.3.1 Europe Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.3.2 Europe Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.3.2.1 Europe Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.3.2.2 Europe Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.3.3 Europe Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      - 9.1.4 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
      - 9.1.5 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
      - 9.1.6 Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
        9.1.6.1 Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
        9.1.6.2 Germany Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        9.1.6.2.1 Germany Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.6.2.2 Germany Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.6.2.3 Germany Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.6.3 Germany Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
      - 9.1.7 UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
        9.1.7.1 UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
        9.1.7.2 UK Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        9.1.7.2.1 UK Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.7.2.2 UK Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.7.2.3 UK Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.7.3 UK Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
      - 9.1.8 France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
        9.1.8.1 France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
        9.1.8.2 France Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        9.1.8.2.1 France Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.8.2.2 France Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.8.2.3 France Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.8.3 France Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
      - 9.1.9 Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
        9.1.9.1 Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
        9.1.9.2 Spain Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        9.1.9.2.1 Spain Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.9.2.2 Spain Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.9.2.3 Spain Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.9.3 Spain Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
      - 9.1.10 Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
        9.1.10.1 Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
        9.1.10.2 Italy Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        9.1.10.2.1 Italy Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.10.2.2 Italy Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.10.2.3 Italy Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        9.1.10.3 Italy Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
      10. Europe Colorectal Cancer Market- Industry Landscape
      - 10.1 Overview
      - 10.2 Growth Strategies In The Colorectal Cancer Market, 2016-2019
      - 10.3 Organic Developments
        10.3.1 Overview
        10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2016-2019
      - 10.4 Inorganic Developments
        10.4.1 Overview
        10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2016-2019
      11. Colorectal Cancer Market–Key Company Profiles
      - 11.1 Epigenomics AG
        11.1.1 Key Facts
        11.1.2 Business Description
        11.1.3 Financial Overview
        11.1.4 Product Portfolio
        11.1.5 SWOT Analysis
        11.1.6 Key Developments
      - 11.2 Novigenix SA
        11.2.1 Key Facts
        11.2.2 Business Description
        11.2.3 Financial Overview
        11.2.4 Product Portfolio
        11.2.5 SWOT Analysis
        11.2.6 Key Developments
      - 11.3 Clinical Genomics Technologies Pty Ltd.
        11.3.1 Key Facts
        11.3.2 Business Description
        11.3.3 Financial Overview
        11.3.4 Product Portfolio
        11.3.5 SWOT Analysis
        11.3.6 Key Developments
      - 11.4 EDP Biotech Corporation
        11.4.1 Key Facts
        11.4.2 Business Description
        11.4.3 Financial Overview
        11.4.4 Product Portfolio
        11.4.5 SWOT Analysis
        11.4.6 Key Developments
      - 11.5 Volitionrx Limited
        11.5.1 Key Facts
        11.5.2 Business Description
        11.5.3 Financial Overview
        11.5.4 Product Portfolio
        11.5.5 SWOT Analysis
        11.5.6 Key Developments
      - 11.6 Abbott Laboratories
        11.6.1 Key Facts
        11.6.2 Business Description
        11.6.3 Financial Overview
        11.6.4 Product Portfolio
        11.6.5 SWOT Analysis
        11.6.6 Key Developments
      - 11.7 Amgen Inc.
        11.7.1 Key Facts
        11.7.2 Business Description
        11.7.3 Financial Overview
        11.7.4 Product Portfolio
        11.7.5 Pipeline (Clinical Trials) Portfolio
        11.7.6 SWOT Analysis
        11.7.7 Key Developments
      - 11.8 F. Hoffmann-La Roche AG
        11.8.1 Key Facts
        11.8.2 Business Description
        11.8.3 Financial Overview
        11.8.4 Product Portfolio
        11.8.5 Pipeline (Clinical Trials) Portfolio
        11.8.6 SWOT Analysis
        11.8.7 Key Developments
      - 11.9 Bruker Corporation
        11.9.1 Key Facts
        11.9.2 Business Description
        11.9.3 Financial Overview
        11.9.4 Product Portfolio
        11.9.5 SWOT Analysis
        11.9.6 Key Developments
      - 11.10 Quest Diagnostics Incorporated
        11.10.1 Key Facts
        11.10.2 Business Description
        11.10.3 Financial Overview
        11.10.4 Product Portfolio
        11.10.5 SWOT Analysis
        11.10.6 Key Developments
      - 11.11 Natera, Inc.
        11.11.1 Key Facts
        11.11.2 Business Description
        11.11.3 Financial Overview
        11.11.4 Product Portfolio
        11.11.5 SWOT Analysis
        11.11.6 Key Developments
      - 11.12 Guardant Health, Inc.
        11.12.1 Key Facts
        11.12.2 Business Description
        11.12.3 Financial Overview
        11.12.4 Product Portfolio
        11.12.5 SWOT Analysis
        11.12.6 Key Developments
      12. Appendix
      - 12.1 About The Insight Partners
      - 12.2 Glossary of Terms

Asia Pacific Dental Implants Market Report

North America Logistics Robots Market Report

Summary:
Get latest Market Research Reports on Europe Colorectal Cancer . Industry analysis & Market Report on Europe Colorectal Cancer is a syndicated market report, published as Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country. It is complete Research Study and Industry Analysis of Europe Colorectal Cancer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on 13 March, 2020

1-User License	$3,000.00
Site License	$4,000.00
Enterprise License	$5,000.00

1-User License	2,400.00
Site License	3,200.00
Enterprise License	4,000.00

1-User License	2,802.00
Site License	3,736.00
Enterprise License	4,670.00

1-User License	473,820.00
Site License	631,760.00
Enterprise License	789,700.00

1-User License	250,290.00
Site License	333,720.00
Enterprise License	417,150.00

Report Detail

Request for Sample of this report

Request for Sample of this report

Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country

Table Of Content

TABLE OF CONTENTS

1. Introduction

2. Europe Colorectal Cancer Market – Key Takeaways

3. Research Methodology

4. Europe Colorectal Cancer Market – Market Landscape

5. Europe Colorectal Cancer Market - Key Market Dynamics

6. Colorectal Cancer Market – Europe Analysis

7. Europe Colorectal Cancer Market Analysis And Forecasts To 2027 – Modality

8. Europe Colorectal Cancer Market Analysis– By End User

9. Colorectal Cancer Market Revenue And Forecasts To 2027 – Geographical Analysis

10. Europe Colorectal Cancer Market- Industry Landscape

11. Colorectal Cancer Market–Key Company Profiles

12. Appendix

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

Related Reports

Reason to Buy

Trusted By Leaders

Shop With Confidence

Customer Centric

Personalized Solutions

Secure Checkout

Request for Sample of this report

Reports and Markets

Contact Us

Support

Newsletter